Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Sees Large Drop in Short Interest

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) saw a large decline in short interest during the month of June. As of June 15th, there was short interest totaling 11 shares, a decline of 84.1% from the May 31st total of 69 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 1,322 shares, the short-interest ratio is presently 0.0 days.

Institutional Trading of Innovator IBD Breakout Opportunities ETF

Several large investors have recently added to or reduced their stakes in the company. Osaic Holdings Inc. increased its holdings in shares of Innovator IBD Breakout Opportunities ETF by 39.7% in the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after purchasing an additional 597 shares during the period. Susquehanna International Group LLP lifted its holdings in shares of Innovator IBD Breakout Opportunities ETF by 42.6% during the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after purchasing an additional 7,817 shares during the period. Finally, Comprehensive Wealth Management LLC lifted its holdings in shares of Innovator IBD Breakout Opportunities ETF by 122.0% during the fourth quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock worth $850,000 after purchasing an additional 12,859 shares during the period.

Innovator IBD Breakout Opportunities ETF Trading Down 1.9%

Shares of NYSEARCA BOUT traded down $0.95 during midday trading on Friday, reaching $47.90. The company had a trading volume of 4,738 shares, compared to its average volume of 4,305. Innovator IBD Breakout Opportunities ETF has a 1 year low of $35.05 and a 1 year high of $49.41. The business’s 50-day simple moving average is $46.16 and its 200 day simple moving average is $41.53. The stock has a market cap of $16.77 million, a P/E ratio of 28.69 and a beta of 1.04.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.